New valve offers hope for leaky heart condition
NCT ID NCT05486832
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new device called the Cardiovalve TR system for people with a leaky tricuspid heart valve (tricuspid regurgitation). The goal is to see if the device is safe and can reduce the leak. The study involves 157 participants with moderate to severe symptoms. Researchers will measure how far patients can walk and their quality of life after the procedure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRICUSPID REGURGITATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Charité university
Berlin, 10117, Germany
-
Herzzentrum Uniklinik
Cologne, 50937, Germany
-
Uniklinik Bonn
Bonn, 53127, Germany
-
University Heart Center Lübeck
Lübeck, 20251, Germany
-
Universitäres Herz
Hamburg, 20251, Germany
-
Universität Bochum
Bad Oeynhausen, 32545, Germany
-
Universitätsklinikum - Regensburg
Regensburg, 93053, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A new Catheter-Based valve could fix a leaky heart valve without surgery
- New clip device aims to repair leaky heart valve without Open-Heart surgery
- New study aims to simplify care for patients with multiple leaky heart valves
- 5,500 patients to test new heart valve devices in massive safety study
- Heart valve repair devices under 5-Year safety spotlight
- Study aims to find best treatment for leaky heart valve in older adults